Display options
Cite
Cheriyath P, Gorrepati VS, Peters I, et al. High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006. J Clin Med Res. 2010;2(5):201-6doi: 10.4021/jocmr425w.
Cheriyath, P., Gorrepati, V. S., Peters, I., Nookala, V., Murphy, M. E., Srouji, N., & Fischman, D. (2010). High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006. Journal of clinical medicine research, 2(5), 201-6. https://doi.org/10.4021/jocmr425w
Cheriyath, Pramil, et al. "High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006." Journal of clinical medicine research vol. 2,5 (2010): 201-6. doi: https://doi.org/10.4021/jocmr425w
Cheriyath P, Gorrepati VS, Peters I, Nookala V, Murphy ME, Srouji N, Fischman D. High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006. J Clin Med Res. 2010 Oct 11;2(5):201-6. doi: 10.4021/jocmr425w. PMID: 21629541; PMCID: PMC3104666.
Copy Download .nbib Format: NLM
Share it on

J Clin Med Res. 2010 Oct 11;2(5):201-6. doi: 10.4021/jocmr425w.

High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006.

Journal of clinical medicine research

Pramil Cheriyath, Venkata Subhash Gorrepati, Ian Peters, Vinod Nookala, Megan E Murphy, Nadine Srouji, Daniel Fischman

Affiliations

  1. Pinnacle Health/ Harrisburg Hospital, Harrisburg, PA, USA.

PMID: 21629541 PMCID: PMC3104666 DOI: 10.4021/jocmr425w

Abstract

BACKGROUND: Diabetes Mellitus (DM) is a rampantly growing epidemic in the United States, affecting nearly 10% of the adult population. Studies have shown that higher levels of Total Bilirubin (TBili) convey a protective effect with regard to cardiovascular risk. In this study, we will examine the relationship between TBili level and prevalence of DM to discern whether a similar relationship exists.

METHODS: The National Health and Nutrition Examination Survey (NHANES) is a comprehensive survey performed regularly to evaluate the overall health and nutrition status of the United States population. For the purpose of this study, we combined NHANES data collected between 1999 and 2006. Totally 15,876 eligible participants were selected after excluding all patients younger than twenty years, those with a history of abnormal liver function tests, or those who disclosed a history of liver disease. The data collected on these individuals was adjusted for demographic characteristics, as well as risk factors for DM, and was analyzed via multivariate logistic regression, using SAS proc survey methodology.

RESULTS: After age adjustment, increased TBili was associated with 26% reduction in diabetes risk (OR 0.74, 95% CI 0.64 - 0.88). Multivariate analysis, adjusting for all diabetes risk factors assessed, confirmed this association (OR 0.80, 95% CI 0.67 - 0.95).

CONCLUSIONS: Our results show that a higher level of serum TBili is associated with odds of having a lower incidence of DM. This finding supports the hypothesis that the antioxidant nature of TBili, demonstrating a protective effect with regard to the risk of stroke, atherosclerosis, and vasculitis in prior research, also extends to DM risk. Furthermore, research has shown that higher levels of TBili increase glucose mobilization into the cells, leading to more efficient, biologic glucose utilization. There is no doubt that the beneficial effect of TBili is multifactorial; thus further investigation is warranted.

KEYWORDS: Bilirubin; Diabetes; Antioxidant; Protective.

References

  1. Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E829-41 - PubMed
  2. Diabetes Care. 2008 Aug;31(8):1615-20 - PubMed
  3. Free Radic Biol Med. 2006 Jun 15;40(12):2198-205 - PubMed
  4. Circulation. 2006 Oct 3;114(14):1476-81 - PubMed
  5. Mol Pharmacol. 2004 Oct;66(4):773-9 - PubMed
  6. Clin Chem. 1994 Jan;40(1):18-23 - PubMed
  7. J Surg Res. 2001 Mar;96(1):107-13 - PubMed
  8. Am J Med. 2008 Sep;121(9):781-788.e1 - PubMed
  9. Pediatrics. 2005 May;115(5):1411-2 - PubMed
  10. Endocrinology. 2009 May;150(5):2098-108 - PubMed
  11. Exp Biol Med (Maywood). 2003 May;228(5):568-71 - PubMed
  12. Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):166-72 - PubMed
  13. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):155-60 - PubMed
  14. Biochem Pharmacol. 1996 Mar 22;51(6):859-62 - PubMed
  15. Clin Chem. 1998 Dec;44(12):2551-3 - PubMed
  16. Int Angiol. 2002 Mar;21(1):44-52 - PubMed
  17. J Mol Med (Berl). 2003 Aug;81(8):455-70 - PubMed
  18. Nat Med. 2002 Mar;8(3):240-6 - PubMed
  19. Science. 1987 Feb 27;235(4792):1043-6 - PubMed
  20. Am J Physiol Endocrinol Metab. 2009 May;296(5):E1029-41 - PubMed

Publication Types